The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of trifluridine/tipiracil (FTD/TPI) plus bevacizumab in clinical practice for patients with chemorefractory metastatic colorectal cancer: A retrospective comparative study.
 
Yoshinori Kagawa
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; MSD; MSD; MSD; MSD; Sanofi; Sanofi; Sanofi; Sanofi; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Takeda; Takeda; Takeda; Takeda; Yakult Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical
 
Yohei Nose
No Relationships to Disclose
 
Taishi Hata
Speakers' Bureau - Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo
 
Kenji Kawai
No Relationships to Disclose
 
Takuya Sakamoto
No Relationships to Disclose
 
Kohei Murakami
No Relationships to Disclose
 
Yoshiteru Katsura
No Relationships to Disclose
 
Yoshiaki Ohmura
No Relationships to Disclose
 
Toru Masuzawa
No Relationships to Disclose
 
Atsushi Takeno
No Relationships to Disclose
 
Yutaka Takeda
No Relationships to Disclose
 
Kohei Murata
No Relationships to Disclose